Announcement – On-boarding Fee Rise

In order to get connected to the EU Hub, pharmaceutical companies are requested to pay an On-boarding Fee to the European Medicines Verification Organisation (EMVO).

EMVO kindly reminds you that, as it has been already announced in December 2017, another 50% rise in the On-boarding fee will be applied as from 15th of June 2018.

The application of the 50% rise in the amount to be invoiced to the On-boarding Partners (OBPs) will be applicable from the 15th of June 2018. All OBPs that will have uploaded a valid Participation Agreement in step 2.3 of the OBP Portal, signed by their named Authorised Representative, provided a valid copy of proof (step 1.2), and submitted their invoicing information form duly filled-in before that date (step 2.6), will benefit from the current rate.

Please find below the table of EMVO’s On-boarding fee.

(Please note that EMVO reserves its right to potentially apply an additional rise of the On-boarding fee in 2018.) 

More Details:

Find more detailed information from the Letter of Announcement

2018/05/17 | On-boarding Fee Rise